Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03214029 · ClinicalTrials.gov registry record
COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial
A clinical trial of Acute Coronary Syndrome and Acute Myocardial Infarction, sponsored by Hennepin Healthcare Research Institute.
- Active
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT03214029: Active study of Acute Coronary Syndrome and Acute Myocardial Infarction, sponsored by Hennepin Healthcare Research Institute.
NCT03214029 is a study of Acute Coronary Syndrome and Acute Myocardial Infarction that is active but no longer recruiting, run by Hennepin Healthcare Research Institute. The registered enrollment target is 2,000 participants, below the 2,672-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target (25% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03214029, a study of Acute Coronary Syndrome and Acute Myocardial Infarction, is active but no longer recruiting, sponsored by Hennepin Healthcare Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Compare the analytical and clinical performance of hs-cTnI and hs-cTnT assays for the diagnosis of acute myocardial injury and myocardial infarction in patients presenting to the emergency department in whom serial cTnI measurements are obtained on clinical indication.
Primary Outcome
Diagnostic performance of cardiac troponin assays for the diagnosis of acute myocardial injury and myocardial infarction
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Cardiac troponin testing
Study Locations (1)
Minnesota
- Hennepin County Medical Center - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2017-11-06 |
| Est. Completion | 2025-12-31 |
What the registry record for NCT03214029 still lists
NCT03214029 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, below the 2,672-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target (25% lower).
The record links to 2 conditions, with Acute Coronary Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Cardiac troponin testing is the first listed.
NCT03214029 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03214029 about?
NCT03214029 is a clinical study titled "COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial". Compare the analytical and clinical performance of hs-cTnI and hs-cTnT assays for the diagnosis of acute myocardial injury and myocardial infarction in patients presenting to the emergency department in whom serial cTnI measurements are obtained on clinical indication.
What is the current status of trial NCT03214029?
This trial is currently active not recruiting. The enrollment target is 2,000 participants. The study started on 2017-11-06. Estimated completion is 2025-12-31.
What conditions does trial NCT03214029 study?
This clinical trial studies the following conditions: Acute Coronary Syndrome, Acute Myocardial Infarction.
What interventions are being tested in trial NCT03214029?
The interventions under investigation include: Cardiac troponin testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03214029?
This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03214029 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Coronary Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03214029's enrollment target sits among peer trials
2,000 10th of 40 higher than 30 of 40 other Acute Coronary Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Coronary Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Polypill for Acute Coronary Syndrome
RECRUITING · Phase 2
-
Positive Emotions Following Acute Cardiac Events
RECRUITING · NA
-
Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock
RECRUITING
-
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
RECRUITING · Phase 3
-
A Prospective Research Investigation of Ischemia Using MCG
RECRUITING
-
AngelMed Guardian® System PMA Post Approval Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI